Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington’s Disease
- 18 January 2016
- journal article
- Published by Springer Nature in NeuroMolecular Medicine
- Vol. 18 (1) , 146-153
Abstract
Altered dopamine receptor labelling has been demonstrated in presymptomatic and symptomatic Huntington’s disease (HD) gene carriers, indicating that alterations in dopaminergic signalling are an early event in HD. We have previously described early alterations in synaptic transmission and plasticity in both the cortex and hippocampus of the R6/1 mouse model of Huntington’s disease. Deficits in cortical synaptic plasticity were associated with altered dopaminergic signalling and could be reversed by D1- or D2-like dopamine receptor activation. In light of these findings we here investigated whether defects in dopamine signalling could also contribute to the marked alteration in hippocampal synaptic function. To this end we performed dopamine receptor labelling and pharmacology in the R6/1 hippocampus and report a marked, age-dependent elevation of hippocampal D1 and D2 receptor labelling in R6/1 hippocampal subfields. Yet, pharmacological inhibition or activation of D1- or D2-like receptors did not modify the aberrant synaptic plasticity observed in R6/1 mice. These findings demonstrate that global perturbations to dopamine receptor expression do occur in HD transgenic mice, similarly in HD gene carriers and patients. However, the direction of change and the lack of effect of dopaminergic pharmacological agents on synaptic function demonstrate that the perturbations are heterogeneous and region-specific, a finding that may explain the mixed results of dopamine therapy in HD.Keywords
Funding Information
- Open University (GB)
This publication has 48 references indexed in Scilit:
- How do astrocytes shape synaptic transmission? Insights from electrophysiologyFrontiers in Cellular Neuroscience, 2013
- Dopamine D1/D5 Receptors Mediate Informational Saliency that Promotes Persistent Hippocampal Long-Term PlasticityCerebral Cortex, 2012
- Altered Dopamine and Serotonin Metabolism in Motorically Asymptomatic R6/2 MicePLOS ONE, 2011
- Impaired dopamine release and uptake in R6/1 Huntington's disease model miceNeuroscience Letters, 2011
- Postsynaptic nigrostriatal dopamine receptors and their role in movement regulationJournal of Neural Transmission, 2010
- Dopamine and Glutamate in Huntington's Disease: A Balancing ActCNS Neuroscience & Therapeutics, 2010
- Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin miceProceedings of the National Academy of Sciences, 2009
- Understanding memory through hippocampal remappingTrends in Neurosciences, 2008
- Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genesNature Genetics, 2003
- [11C]Raclopride‐PET studies of the Huntington's disease rate of progression: Relevance of the trinucleotide repeat lengthAnnals of Neurology, 1998